Understanding the implications of a shifting opioid landscape in Ontario
Gomes T, Juurlink DN. Healthc Q. 2019; 22(3):6-11. Epub 2019 Oct 1.
Publications
One-year mortality after emergency department visit for nonfatal opioid poisoning: a population-based analysis
Leece P, Chen C, Manson H, Orkin AM, Schwartz B, Juurlink DN, Gomes T. Ann Emerg Med. 2020; 75(1):20-8. Epub 2019 Sep 24.
Time trends in opioid prescribing among Ontario long-term care residents: a repeated cross-sectional study
Iaboni A, Campitelli MA, Bronskill SE, Diong C, Kumar M, Maclagan LC, Gomes T, Tadrous M, Maxwell CJ. CMAJ Open. 2019; 7(3):E582-9. Epub 2019 Sep 23.
Unplanned index hospital admissions among new older high-cost healthcare users in Ontario: a population-based matched cohort study
Muratov S, Lee J, Holbrook A, Paterson JM, Guertin JR, Mbuagbaw L, Gomes T, Khuu W, Pequeno P, Tarride JE. CMAJ Open. 2019; 7(3):E537-45. Epub 2019 Aug 25.
Healthcare resource utilization and costs among patients with direct oral anticoagulant or warfarin-related major bleeding
Xu Y, Schulman S, Dowlatshahi D, Holbrook AM, Simpson CS, Shepherd LE, Wells PS, Giulivi A, Gomes T, Mamdani M, Frymire E, Khan S, Johnson AP; Bleeding Effected by Direct Oral Anticoagulants (BLED-AC) Study Group. Thromb Res. 2019; 182:12-9. Epub 2019 Aug 2.
Antipsychotic initiation among adults with intellectual and developmental disabilities in Ontario: a population-based cohort study
Gomes T, Khuu W, Tadrous M, Vigod S, Cobigo V, Lunsky Y. BMJ Open. 2019; 9:e028125. Epub 2019 Jul 31.
Association of mirabegron with the risk of arrhythmia in adult patients 66 years or older—a population-based cohort study
Tadrous M, Matta R, Greaves S, Herschorn S, Mamdani MM, Juurlink DN, Gomes T. JAMA Intern Med. 2019; 179(10):1436-9. Epub 2019 Jul 15.
Quality of primary care among individuals receiving treatment for opioid use disorder
Spithoff S, Kiran T, Khuu W, Kahan M, Guan Q, Tadrous M, Leece P, Martins D, Gomes T. Can Fam Physician. 2019; 65(5):343-51. Epub 2019 May 1.
Impact of delisting high‐strength opioid formulations from a public drug benefit formulary on opioid utilization in Ontario, Canada
Martins D, Khuu W, Tadrous M, Juurlink DN, Mamdani MM, Paterson JM, Gomes T. Pharmacoepidemiol Drug Saf. 2019; 28(5):726-33. Epub 2019 Mar 14.
Evaluation of the fentanyl patch-for-patch program in Ontario, Canada
Tadrous M, Greaves S, Martins D, Nadeem K, Singh S, Mamdani MM, Juurlink DN, Gomes T. Int J Drug Policy. 2019; 66:82-6. Epub 2019 Feb 8.